According to the American Society of Clinical Oncology, around 2.4lac adults in the United States will be diagnosed with lung cancer of which 81% are NSCLC. Early diagnosis and treatment is one…
Tag: Treating Lung Cancer
FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with NSCLC (non-small cell lung cancer). This approval has been based on the…
Columbia Biomedical Engineers Develop New Bacterial Therapy for Lung Cancer Treatment
Lung cancer is one of the most deadly types of cancers in the United States as well as around the world. As most of the therapies have been ineffective, this leaves patients…
Plant Compound Berberine May Help Fight Lung Cancer
Lung cancer is the leading cause of cancer related deaths among men and women and the scientific community continues to make efforts to find new ways for lung cancer treatment. In a…
What Is Liquid Biopsy For Lung Cancer?
Lung cancer remains the most frequently diagnosed cancer type and is the leading cause of cancer related deaths worldwide. Most lung cancer patients have distant metastasis at initial diagnosis of lung cancer…
FDA Approves FoundationOne CDx in Non-Small Cell Lung Cancer
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for patients with non-small cell lung cancer. This approval applies to the use…
Lung Cancer Treatment May Impact Daily Function in Elderly Patients
According to the new research published in Journal of the American Geriatrics Society, older adults with lung cancer may experience decline in life-space mobility during lung cancer treatment. The study has been…
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…